Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.06 USD | +0.84% | +0.08% | +343.38% |
May. 10 | Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 23 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Transportation Index | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 338M |
---|---|---|---|---|---|
Net income 2024 * | -31M | Net income 2025 * | -43M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.03
x | P/E ratio 2025 * |
-8.63
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.92% |
1 day | +0.84% | ||
1 week | +0.08% | ||
Current month | -6.73% | ||
1 month | -6.15% | ||
3 months | +67.50% | ||
6 months | +678.06% | ||
Current year | +343.38% |
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18-01-18 |
Director of Finance/CFO | - | 21-10-04 | |
Chief Tech/Sci/R&D Officer | 52 | 22-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 20-08-06 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 21-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 23-08-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 12.06 | +0.84% | 42,933 |
24-05-23 | 11.96 | -0.17% | 35,087 |
24-05-22 | 11.98 | -0.25% | 41,676 |
24-05-21 | 12.01 | +0.08% | 37,248 |
24-05-20 | 12 | -0.41% | 36,152 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+343.38% | 338M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- EMBI Stock